BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37169262)

  • 1. Side Effects of Proton Beam Radiotherapy Treatment on Iris Melanoma.
    Eibenberger K; Heimann H; Gatchalian L; Kacperek A; Hussain R
    Ophthalmology; 2023 Sep; 130(9):958-965. PubMed ID: 37169262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton beam radiotherapy of iris melanoma.
    Damato B; Kacperek A; Chopra M; Sheen MA; Campbell IR; Errington RD
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):109-15. PubMed ID: 16111578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton Therapy for 166 Patients with Iris Melanoma: Side Effects and Oncologic Outcomes.
    Gollrad J; Böker A; Vitzthum S; Besserer A; Heufelder J; Gauger U; Böhmer D; Budach V; Zeitz O; Joussen AM
    Ophthalmol Retina; 2023 Mar; 7(3):266-274. PubMed ID: 36087876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects.
    Riechardt AI; Klein JP; Cordini D; Heufelder J; Rehak M; Seibel I; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1325-1332. PubMed ID: 29464331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton beam radiotherapy of diffuse iris melanoma in 54 patients.
    Willerding GD; Cordini D; Hackl C; Karle B; Lakotka N; Foerster MH; Bechrakis NN; Heufelder J; Moser L; Joussen AM
    Br J Ophthalmol; 2015 Jun; 99(6):812-6. PubMed ID: 25505288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes.
    Shields CL; Shah SU; Bianciotto CG; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2013 Jan; 120(1):55-61. PubMed ID: 22980742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plaque radiotherapy for residual or recurrent iris melanoma after surgical resection in 32 cases.
    Shah SU; Shields CL; Bianciotto C; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2012 Apr; 119(4):838-842.e2. PubMed ID: 22133794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton therapy of iris melanoma with 50 CGE : Influence of target volume on clinical outcome.
    Riechardt AI; Karle B; Cordini D; Heufelder J; Budach V; Joussen AM; Gollrad J
    Strahlenther Onkol; 2017 Nov; 193(11):943-950. PubMed ID: 28631017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton beam therapy for iris melanoma: a review of 15 cases.
    Rundle P; Singh AD; Rennie I
    Eye (Lond); 2007 Jan; 21(1):79-82. PubMed ID: 16410818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole anterior segment proton beam radiotherapy for diffuse iris melanoma.
    Konstantinidis L; Roberts D; Errington RD; Kacperek A; Damato B
    Br J Ophthalmol; 2013 Apr; 97(4):471-4. PubMed ID: 23298884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications.
    Shields CL; Naseripour M; Shields JA; Freire J; Cater J
    Am J Ophthalmol; 2003 May; 135(5):648-56. PubMed ID: 12719072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton Beam Therapy for Iris Melanomas in 107 Patients.
    Thariat J; Rahmi A; Salleron J; Mosci C; Butet B; Maschi C; Lanza F; Lanteri S; Baillif S; Herault J; Mathis T; Caujolle JP
    Ophthalmology; 2018 Apr; 125(4):606-614. PubMed ID: 29128229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary Glaucoma due to Iridescent Crystalline Particles Masquerading as Refractory Hypertensive Uveitis in an Eye With Irradiated Iris Melanoma.
    Chahal R; Mohite AA; Heimann H; Bansal A
    J Glaucoma; 2018 Apr; 27(4):385-388. PubMed ID: 29394206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton beam therapy for iris melanomas.
    Lumbroso-Le Rouic L; Delacroix S; Dendale R; Levy-Gabriel C; Feuvret L; Noel G; Plancher C; Nauraye C; Garcia P; Calugaru V; Asselain B; Desjardins L
    Eye (Lond); 2006 Nov; 20(11):1300-5. PubMed ID: 16294207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton beam therapy for presumed and confirmed iris melanomas: a review of 36 cases.
    Rahmi A; Mammar H; Thariat J; Angellier G; Herault J; Chauvel P; Kodjikian L; Denis P; Grange JD
    Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1515-21. PubMed ID: 25038910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
    Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
    Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton beam therapy of parapapillary choroidal melanoma.
    Riechardt AI; Cordini D; Willerding GD; Georgieva I; Weber A; Seibel I; Lakotka N; Bechrakis NE; Foerster MH; Moser L; Joussen AM
    Am J Ophthalmol; 2014 Jun; 157(6):1258-65. PubMed ID: 24548873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic findings in treatment-naïve and proton-beam-radiated iris melanomas.
    Krishna Y; Kalirai H; Thornton S; Damato BE; Heimann H; Coupland SE
    Br J Ophthalmol; 2016 Jul; 100(7):1012-1016. PubMed ID: 27098748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of iris melanoma after proton beam therapy.
    Sandinha MT; Kacperek A; Errington RD; Coupland SE; Damato B
    Br J Ophthalmol; 2014 Apr; 98(4):484-7. PubMed ID: 24414401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapeutic and surgical management of iris melanoma: A review.
    Popovic M; Ahmed IIK; DiGiovanni J; Shields CL
    Surv Ophthalmol; 2017; 62(3):302-311. PubMed ID: 28062196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.